luster headache, a neurological disorder is a condition characterized by severe headaches recurring on one side of the head usually around the eye. Cluster headache is often accompanied by autonomic symptoms such as excessive tears, swelling of the eye and nasal decongestion. In cluster headache syndrome, individuals often suffer from excruciating attacks of unilateral headaches. Some symptoms like migraine such as sensitivity to light and sound, nausea may also occur with a cluster headache. The causes of cluster headache are not completely known, though some of the rare causes may be hereditary, smoking and dysfunction of hypothalamus. The intense pain is known to be caused by dilation of blood vessels creating pressure on the trigeminal nerve. Diagnosis of cluster headache syndrome can be often misleading, mismanaged and misdiagnosed. The cluster headache attacks often occur multiple times in a day, each attack lasting not more than three hours without treatment. The attacks occur daily for several weeks or months and then diminish for a period, though they can last for months or even years in some people. Prevalence of cluster headache syndrome in men is three to four times more than in women.
This report elaborates the market size, market characteristics, and market growth of the Cluster Headache Syndrome industry, and breaks down according to the type, application, and consumption area of Cluster Headache Syndrome. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Cluster Headache Syndrome in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Cluster Headache Syndrome market covered in Chapter 13:
Teva Pharmaceutical Industries Ltd
Winston Pharmaceuticals
AstraZeneca
Crossject SA
Novartis AG
Autonomic Technologies
Center Laboratories Inc
GlaxoSmithKline plc
Eli Lilly and Co
ElectroCore Medical LLC
TrioxBio Inc

In Chapter 6, on the basis of types, the Cluster Headache Syndrome market from 2015 to 2025 is primarily split into:
Calcium Channel Blockers
Corticosteroids
Sumatriptan
Lithium Carbonate
Ergots
Melatonin
Anti-seizure
Local Anesthetics

In Chapter 7, on the basis of applications, the Cluster Headache Syndrome market from 2015 to 2025 covers:
Hospitals Clinics
Private Clinics
Retail Pharmacies and Drug Stores
E-commerce

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025